Changes in glomerular filtration rate after cardiac surgery with cardiopulmonary bypass in patients with mild preoperative renal dysfunction

Cardiac surgery with cardiopulmonary bypass (CPB) is commonly perceived as a risk factor for decline in renal function, especially in patients with preoperative renal dysfunction. There are few data on the effects of CPB on renal function in patients with mild preoperative renal dysfunction. The pur...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of anaesthesia : BJA Vol. 100; no. 6; pp. 759 - 764
Main Authors Loef, B.G., Henning, R.H., Navis, G., Rankin, A.J., van Oeveren, W., Ebels, T., Epema, A.H.
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 01.06.2008
Oxford University Press
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cardiac surgery with cardiopulmonary bypass (CPB) is commonly perceived as a risk factor for decline in renal function, especially in patients with preoperative renal dysfunction. There are few data on the effects of CPB on renal function in patients with mild preoperative renal dysfunction. The purpose of this study was to evaluate renal function in patients with pre-existing mild renal dysfunction undergoing cardiac surgery with CPB. In a multicentre study cohort we measured prospectively the glomerular filtration rate (GFR) by radioactive markers both before operation and on the 7th postoperative day in cardiac surgical patients with preoperative serum creatinine >120 μmol l−1 (n=56). In a subgroup of patients (n=14) in addition to the GFR, the effective renal plasma flow (ERPF) and the filtration fraction (FF) were measured. While preoperative GFR [77.9 (25.5) ml min−1] increased to 84.4 (23.7) ml min−1 (P=0.005) 1 week after surgery, ERPF did not change [295.8 (75.2) ml min−1 and 295.9 (75.9) ml min−1, respectively; P=0.8]. In accordance, the FF increased from 0.27 (0.05) (before operation) to 0.30 (0.04) (Day 7, P=0.01). Our results oppose the view that cardiac surgery with CPB adversely affects renal function in patients with preoperative mild renal dysfunction and an uncomplicated clinical course.
Bibliography:ArticleID:aen081
istex:D675F2AD21A4F7A1CC042B3CF700800E06FE291A
ark:/67375/HXZ-D5SKH0B1-W
Declaration of interest. A. J. Rankin is a research employee of Pfizer Global Research and Development, Kent, UK.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0007-0912
1471-6771
DOI:10.1093/bja/aen081